Breaking News Instant updates and real-time market news.

MRK

Merck

$61.35

-0.95 (-1.52%)

13:23
11/22/16
11/22
13:23
11/22/16
13:23

Merck increases dividend by 1c to 47c per share

Merck announced that the board has increased the company's quarterly dividend to 47c per outstanding share of the company's common stock, up 1c from 46c per outstanding share paid last quarter. Payment will be made on Jan. 9, 2017, to stockholders of record at the close of business on Dec. 15, 2016. "We are making strides toward our overarching goal of bringing forward medicines and vaccines that create value for society and shareholders alike. The dividend increase reflects our confidence in our innovation strategy and our commitment to returning meaningful value to our shareholders," said chairman and CEO Kenneth Frazier.

MRK Merck
$61.35

-0.95 (-1.52%)

10/13/16
10/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Buy from Neutral at BofA/Merrill with analyst Colin Bristow citing its opportunity in first line lung cancer. 2. Viacom (VIA, VIAB) upgraded to Market Perform from Underperform at Wells Fargo and to Buy from Underperform at BofA/Merrill. 3. TD Ameritrade (AMTD) and Charles Schwab (SCHW) were upgraded to Buy from Neutral at BofA/Merrill. 4. Talend (TLND) upgraded to Buy from Neutral at Goldman with analyst Jesse Hulsing saying the company will benefit from analytic workloads moving to the cloud. 5. CSC (CSC) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/19/16
LEER
10/19/16
NO CHANGE
LEER
Roche Tecentriq approval increases competition, says Leerink
Leerink analyst Seamus Fernandez says that the FDA approval of Roche's (RHHBY) Tecentriq in second-line non-small cell lung cancer patients regardless of PD-L1 expression comes as no surprise given its previously reported overall survival advantage. Nonetheless, the analyst believes it creates new competition for Bristol-Myers' (BMY) Opdivo and Merck's (MRK) Keytruda in this setting.
10/24/16
RHCO
10/24/16
NO CHANGE
RHCO
Merck Keytruda to have several positive catalysts, says SunTrust
SunTrust analyst John Boris says that several trials of Merck's Keytruda will be stopped early "across multiple tumor types," providing a positive catalyst. Boris says that Keytruda should be approved for 1LNSCLC on or before December 24 and KN-21 chemo combo compendium listing in 1H17. He keeps a $73 price target and Buy rating on Merck.
10/25/16
RHCO
10/25/16
NO CHANGE
RHCO
Merck shares should be bought after early FDA approval, says SunTrust
After Merck announced that the FDA had approved the company's Keytruda treatment for the first-line metastatic non-small cell lung cancer with tumor proportion scores of 50% or higher, SunTrust analyst John Boris says that such patients represent about 30% "of the prevalent first-line population." He adds that the approval was earlier than expected and gives Keytruda an approximately 15 month lead over competing drugs in NSCLC. The analyst thinks that the early approval will enable the company's 2021 revenue to beat expectations by a significant amount, and he recommends buying the stock on the news.

TODAY'S FREE FLY STORIES

AR

Antero Resources

$20.34

0.04 (0.20%)

10:03
09/21/17
09/21
10:03
09/21/17
10:03
Downgrade
Antero Resources rating change  »

Follow-up: Antero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMP

Oasis Midstream Partners

, OAS

Oasis Petroleum

$8.68

-0.23 (-2.58%)

10:03
09/21/17
09/21
10:03
09/21/17
10:03
Syndicate
Breaking Syndicate news story on Oasis Midstream Partners, Oasis Petroleum »

Oasis Midstream Partners…

OMP

Oasis Midstream Partners

OAS

Oasis Petroleum

$8.68

-0.23 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 21

    Sep

10:02
09/21/17
09/21
10:02
09/21/17
10:02
General news
Leading Indicators data reported »

August Leading Indicators…

GLD

SPDR Gold Trust

$122.83

-0.79 (-0.64%)

10:01
09/21/17
09/21
10:01
09/21/17
10:01
Options
One-day put seller in SPDR Gold Fund »

One-day put seller in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
09/21/17
09/21
10:00
09/21/17
10:00
General news
Fed funds futures are little changed inside a very narrow trading ranges »

Fed funds futures are…

ARI

Apollo Commercial

$18.35

0.065 (0.36%)

09:59
09/21/17
09/21
09:59
09/21/17
09:59
Conference/Events
Apollo Commercial management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ALB

Albemarle

$135.68

-0.405 (-0.30%)

09:59
09/21/17
09/21
09:59
09/21/17
09:59
Conference/Events
Albemarle management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

AFSI

AmTrust

$12.90

0.01 (0.08%)

09:57
09/21/17
09/21
09:57
09/21/17
09:57
Conference/Events
AmTrust management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AAPL

Apple

$156.07

-2.66 (-1.68%)

09:57
09/21/17
09/21
09:57
09/21/17
09:57
Technical Analysis
Technical View: Apple edges below uptrend support line »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AR

Antero Resources

$20.21

-0.09 (-0.44%)

09:56
09/21/17
09/21
09:56
09/21/17
09:56
Downgrade
Antero Resources rating change  »

Antero Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$50.66

0.12 (0.24%)

09:55
09/21/17
09/21
09:55
09/21/17
09:55
Hot Stocks
Alkermes CEO highlights study showing opioids reduce life expectancy »

Alkermes CEO Richard Pops…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

APC

Anadarko

$47.29

2.48 (5.53%)

, PEG

PSEG

$45.88

0.645 (1.43%)

09:55
09/21/17
09/21
09:55
09/21/17
09:55
Options
Early notable gainers among liquid option names on September 21st »

Notable gainers among…

APC

Anadarko

$47.29

2.48 (5.53%)

PEG

PSEG

$45.88

0.645 (1.43%)

SLG

SL Green Realty

$98.99

1.27 (1.30%)

TSS

TSYS

$68.28

0.83 (1.23%)

CF

CF Industries

$35.50

0.31 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 27

    Sep

  • 05

    Nov

AMD

AMD

$13.74

0.62 (4.73%)

09:53
09/21/17
09/21
09:53
09/21/17
09:53
Options
Flurry of activity in AMD calls early-Thursday »

Flurry of activity in AMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMP

Oasis Midstream Partners

, OAS

Oasis Petroleum

$8.83

-0.085 (-0.95%)

09:51
09/21/17
09/21
09:51
09/21/17
09:51
Syndicate
Breaking Syndicate news story on Oasis Midstream Partners, Oasis Petroleum »

Oasis Midstream Partners…

OMP

Oasis Midstream Partners

OAS

Oasis Petroleum

$8.83

-0.085 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 21

    Sep

KEG

Key Energy

$12.59

-0.05 (-0.40%)

09:50
09/21/17
09/21
09:50
09/21/17
09:50
Initiation
Key Energy initiated  »

Key Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXPE

Expedia

$143.01

1.54 (1.09%)

, GOOG

Alphabet

$931.58

9.77 (1.06%)

09:49
09/21/17
09/21
09:49
09/21/17
09:49
Periodicals
Expedia CEO says HomeAway unit profit goal may need shifting, Skift reports »

Expedia (EXPE) CEO Mark…

EXPE

Expedia

$143.01

1.54 (1.09%)

GOOG

Alphabet

$931.58

9.77 (1.06%)

GOOGL

Alphabet Class A

$947.54

10.68 (1.14%)

AMZN

Amazon.com

$973.21

3.35 (0.35%)

MSFT

Microsoft

$74.94

-0.5 (-0.66%)

AAPL

Apple

$156.07

-2.66 (-1.68%)

FB

Facebook

$172.17

-0.35 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 02

    Oct

  • 22

    Oct

  • 29

    Nov

HON

Honeywell

$139.09

0.4 (0.29%)

09:48
09/21/17
09/21
09:48
09/21/17
09:48
Recommendations
Honeywell could rally over 14% on portfolio shakeup, says Deutsche Bank »

Honeywell is expected to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBUU

Malibu Boats

$28.53

0.2 (0.71%)

09:48
09/21/17
09/21
09:48
09/21/17
09:48
Periodicals
Breaking Periodicals news story on Malibu Boats »

Malibu Boats mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$10.66

-0.31 (-2.83%)

09:47
09/21/17
09/21
09:47
09/21/17
09:47
Recommendations
GoPro analyst commentary  »

GoPro unit and earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:46
09/21/17
09/21
09:46
09/21/17
09:46
General news
Bloomberg Consumer Comfort Index Level data reported »

Week of 9/17 Bloomberg…

JD

JD.com

$44.44

0.11 (0.25%)

09:45
09/21/17
09/21
09:45
09/21/17
09:45
Recommendations
JD.com analyst commentary  »

JD.com estimates cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
09/21/17
09/21
09:45
09/21/17
09:45
General news
U.S. leading indicators preview: »

U.S. leading indicators…

09:45
09/21/17
09/21
09:45
09/21/17
09:45
General news
Leading Indicators to be reported at 10:00 »

August Leading Indicators…

ALIOF

Actelion

$277.27

-2.73 (-0.98%)

09:45
09/21/17
09/21
09:45
09/21/17
09:45
Conference/Events
Actelion has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

OMP

Oasis Midstream Partners

, OAS

Oasis Petroleum

09:44
09/21/17
09/21
09:44
09/21/17
09:44
Syndicate
Breaking Syndicate news story on Oasis Midstream Partners, Oasis Petroleum »

Oasis Midstream Partners…

OMP

Oasis Midstream Partners

OAS

Oasis Petroleum

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 21

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.